Skip to main content

Table 1 Patients' characteristics

From: Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis – a CMR study

Nr Gender Age CAD excluded invasively ECG Ck (U/l) Troponin (ug/l) BP (mmHg) BP-FU (mmHg) Initial medication Medication at FU
1 Male 20 no ST-Elevation II, III, aVF, V3-5 T-Inversion I, aVL 443 Troponin I 39.0 125/75 110/60 Metoprolol, Ramipril Metoprolol, Ramipril
2 Male 36 yes ST-Elevation V5–V9 T-Inversion III, aVF 407 Troponin I 8.5 138/74 146/92 Metoprolol, Ramipril None
3 Male 50 yes ST-Elevation I, II, aVF, V5-6 609 Troponin I 70.0 105/70 n/a Metoprolol, Ramipril None
4 Female 50 yes ST-Elevation V1, V2 T-Inversion I, II, aVL, aVF, V2–V6   Troponin I 1.3 120/70 117/49 Ramipril Ramipril
5 Male 38 yes ST-Elevation II, III, aVF, V5-6 213 Troponin I 15.7 130/75 110/80 Ramipril None
6 Female 66 yes T-Inversion I, II, aVL, V2-6 547 Troponin T 1.8 118/73 122/70 Metoprolol, Ramipril Metoprolol, Ramipril
7 Male 51 yes ST-Elevation V2-5 T-Inversion III 349 Troponin T 1.6 n/a 160/96 Metoprolol, Ramipril Metoprolol
8 Female 24 yes AV-Block III 125 Troponin T 0.2 120/60 112/51 Metoprolol, Candesartan None
9 Male 35 yes ST-Elevation I, II, aVF, V1-3, V5-6 166 Troponin T 0.22 120/75 n/a Ramipril Ramipril
10 Male 26 no ST-Elevation I, II, aVF, V4–V6 85 Troponin I 2.0 125/80 120/80 Metoprolol, Ramipril Metoprolol, Ramipril
11 Male 37 yes ST-Elevation I, II, aVL, V4-6 1100 Troponin I 103.0 120/75 115/70 Metoprolol, Ramipril Metoprolol, Ramipril
12 Female 63 yes ST-Elevation I, II, aVL, V5-6 T-Inversion III 429 Troponin I 70.1 130/75 100/60 Metoprolol, Ramipril Ramipril
13 Male 18 yes ST-Elevation II, III, aVF, V5-6 T-Inversion II, III, aVF, V5-6 168 Troponin I 41.0 120/70 122/56 Metoprolol, Ramipril None
14 Male 25 yes ST-Elevation II, III, aVF 1767 Troponin I 198.0 115/70 130/80 Metoprolol, Ramipril Metoprolol
15 Male 40 yes ST-Elevation I, II, aVL, V5-6 T-Inversion III 594 Troponin T 1.0 n/a n/a Metoprolol, Ramipril None
16 Male 18 no initially Afib., later ST-Elevation II, aVF, V3-6 148 Troponin I 0.4 120/70 120/70 Metoprolol, Ramipril Metoprolol, Ramipril
17 Male 67 yes ST-Elevation II, III, aVF, V4-6 213 Troponin I 0.4 125/75 130/80 Metoprolol, Ramipril None
18 Female 43 yes T-Inversion V1–V3 205 Troponin I 0.4 120/75 130/80 Metoprolol, Ramipril Metoprolol, Ramipril
19 Male 18 yes ST-Elevation I, II 52 Troponin I 0.4 120/70 125/95 Metoprolol, Ramipril, Torasemid Metoprolol, Ramipril
20 Male 16 no ST-Elevation II, III, aVF 82 Troponin I 0.3 120/70 130/80 Ramipril Ramipril
21 Male 23 no ST-Elevation I, II, aVF, V2-5 T-Inversion III 570 Troponin I 0.3 120/60 124/72 None None
  1. Patients' clinical data at admission (Ck: creatine kinase, CAD: coronary artery disease, BP: blood pressure, FU: follow-up)